Results 71 to 80 of about 84,212 (322)

Performance of Two‐Tiered Subclassification of Atypia of Undetermined Significance in Thyroid Fine‐Needle Aspiration Without Routine Molecular Testing

Diagnostic Cytopathology, EarlyView.
ABSTRACT Background The third edition of the Bethesda system for reporting thyroid cytopathology recommends a simplified two‐tiered subclassification of atypia of undetermined significance (AUS), dividing cases into AUS with nuclear atypia (AUS‐Nuclear) and other atypia (AUS‐Other).
Pocholo D. Santos, Chiung‐Ru Lai, Jen‐Fan Hang   +2 more
wiley   +1 more source

Fourth Branchial Anomalies: Diagnosis, Treatment, and Long-Term Outcome

Frontiers in Surgery, 2021
Introduction: Fourth branchial anomalies, the rarest among anomalies of the branchial apparatus, often present diagnostic and therapeutic challenges.
Annelien Boonen, Greet Hens, Jeroen Meulemans, Jeroen Meulemans, Robert Hermans, Pierre Delaere, Vincent Vander Poorten, Vincent Vander Poorten   +7 more
doaj   +1 more source

Defining the role of systemic autoimmune markers in adult epilepsy: A focus on autoimmune‐associated epilepsy

Epilepsia Open, EarlyView.
Abstract Objective Autoimmune mechanisms are a recognized cause of adult epilepsy, with immunotherapy offering etiology‐specific treatment. Autoimmune‐associated epilepsy is an emerging clinical entity, for which early diagnosis remains challenging and largely depends on neuronal antibody testing.
I‐Ting Lin, Chiehyu Shen, Chi‐Ting Chung, Chang‐Yu Edward Cheng, Pin‐Yu Chen, Tun Jao   +5 more
wiley   +1 more source

Enfortumab vedotin plus pembrolizumab in treatment‐naïve metastatic urothelial carcinoma patients: An Austrian real‐world analysis

International Journal of Cancer, EarlyView.
What's New? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke, Karl Mayrhofer, Johanna Krauter, Johannes Franke, Dominic Vais, Maximillian Pallauf, David Kiesl, Ferdinand Luger, Jacob Pfuner, Angelika Terbuch, Thomas Bauernhofer, Jasmin Spielgelberg, Andreas Banner, Stefan Aufderklamm, Clemens Wiesinger, Susanne Schnabel, Simon Peter Gampenrieder, Josef Mühlmann, Sonia Vallet, Sabine Weibrecht, Franz Stoiber, Haleh Andalibi, Harun Fajkovic, Hossein Taghizadeh, Jan Miechowiecki, Roman Taedcke, Daniel Heintel, Shahrokh F. Shariat, Martin Pichler, Wolfgang Hilbe, Renate Pichler   +30 more
wiley   +1 more source

Hashimoto's Thyroiditis-Associated Acute Renal Failure and Pitfalls of eGFR Interpretation in Thyroid Diseases

European Journal of Case Reports in Internal Medicine, 2021
The authors describe a patient with severe hypothyroidism due to Hashimoto’s thyroiditis and describe the pitfalls of estimated glomerular filtration rate interpretation in such cases.
Frank-Peter Tillmann, Ana Harth, Achim Jörres   +2 more
doaj   +1 more source

Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk criteria—A multi‐center retrospective analysis on behalf of the GUARDIANS group

International Journal of Cancer, EarlyView.
What's New? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel, Linus Materna, Ramona Stelmach, Stefanie Zschäbitz, Stephanie Neuberger, Can D. Aydogdu, Jozefina Casuscelli, Timo Egenolf, Matteo Silberg, Julie Steinestel, Arne Strauss, Florian Kirchhoff, Marit Ahrens, Pia Paffenholz, Richard Cathomas, Berna C. Özdemir, Christopher Gossler, Philipp Ivanyi, Marc Rehlinghaus, Thomas Hilser, Viktor Grünwald, Katrin Schlack   +21 more
wiley   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox, Rosinder Kaur, Kugajeevan Vigneswaran, Rachel Small, Jenny Carter, Keelin O'Donoghue, Alexander E. P. Heazell, Anna L. David, Nigel Simpson, Angharad Care, Lisa Starrs, Andrew Shennan, Catalina María Valencia González, Priya Soma‐Pillay, Leah Fitzsimmons, Adam J. Devall, Arri Coomarasamy, Mid‐trimester Pregnancy Loss Guideline Consensus Panel, Owen Arthurs, Ruth Bender‐Atik, Phil Bennett, Kirstien Boelaert, Elizabeth Bonney, Leanna Brace, Naomi Carlisle, Davide Casagrandi, Manju Chandiramani, Carolyn Chiswick, Alexandra Emms, Stella Fielder, James Goadsby, Laura Goodfellow, Jim Gray, Jemma Johns, Emma Kirk, Will Lester, Sophie Mackay, Maria Memtsa, Katie Morris, Sunbal Mukhtar, Naimah Raza, Rita Sarquis, Neil Sebire, Lucy Smith, Lucy Spencer, Amos Tetteh, Natalie Woodhead   +46 more
wiley   +1 more source

Gut microbiota and thyroid diseases – summary of current knowledge

Quality in Sport
Introduction and purpose: The gut microbiota is a diverse collection of microorganisms that coexist in the human intestine. Disorders in its structure leads to dysregulation of huge number of organs, including the thyroid.
Aleksander Daniluk, Kaja Iwaniuk, Martyna Wojda, Magdalena Świstowska, Aleksandra Wielgosz   +4 more
doaj   +1 more source

Silent thyroiditis following vaccination against COVID-19: report of two cases [PDF]

, 2022
Marco Capezzone, M. Tosti-Balducci, Eugenia Morabito, Gian Piero Caldarelli, Alfonso Sagnella, Silvia Cantara, Mario Alessandri, Maria Grazia Castagna   +7 more
openalex   +1 more source

A higher incidence of cardiovascular complications in hyperthyroid patients with Graves’ disease in comparison to hyperthyroid patients with subacute thyroiditis

Zdravniški Vestnik
Background: Hyperthyroidism, as well as systemic inflammation, are associated with a higher incidence and complications of cardiovascular disease. Both in Graves’ disease and subacute thyroiditis, patients are hyperthyroid.
Ana Šešek, Simona Gaberšček, Katja Zaletel, Edvard Pirnat, Katica Bajuk Studen   +4 more
doaj   +1 more source